Sanofi doubles down on Earendil in $160M near-term deal
赛诺菲加码Earendil，达成1.6亿美元短期协议

Sanofi is double-dipping with AI-driven biologics developer Earendil Labs in a deal worth up to $160 million in upfront and near-term checks.
赛诺菲与AI驱动的生物制剂开发商Earendil Labs再度牵手，交易总额最高可达1.6亿美元，包括预付款和短期里程碑。